Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
NCT03257462
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Congenital Adrenal Hyperplasia
CAH - Congenital Adrenal Hyperplasia
Interventions
DRUG:
SPR001
Sponsor
Spruce Biosciences